Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/17/2003US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems
06/17/2003US6579699 Method for producing fermentative product and stress-resistant microorganism
06/17/2003US6579698 Of subtilisn from Streptomyces of given sequence comprising substitution mutation; used in detergents and cleaning products
06/17/2003US6579695 Phosphopantetheinyl transferases and uses thereof
06/17/2003US6579693 Comprising nucleic acids encoding human NADPH-cytochrome reductase and human cytochrome; inactivated genes; contacting a chemical compound with an enzyme preparation to determine the metabolites from the degradation of the compound
06/17/2003US6579692 Method of screening apoptosis inducing substances
06/17/2003US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor
06/17/2003US6579689 Modulation of γ-secretase activity
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579679 Detecting the expression of a presenilin-2 splicing variant lacking exon 5 using nucleic acids or polypeptides; use in diagnosis and treatment of Alzheimer's disease
06/17/2003US6579678 Identifying evolved polynucleotides using recursive sequence recombination; recombining overlapping nucleotide sequences; screening for desired property; use in correlating different combinations of mutations with a desired result
06/17/2003US6579677 Compositions and methods for plant pathogen resistance
06/17/2003US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs
06/17/2003US6579675 Methods for identifying nucleic acid sequences encoding agents that effect cellular phenotypes
06/17/2003US6579674 Administering antisense VA 1 (ava 1) oligodeoxynucleotides with carrier
06/17/2003US6579528 Vaccines; genetically engineering
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003US6579524 Polypeptide having amino acid sequence of C-terminal part of circumsporozoite protein of Plasmodium; oxidized cysteine residue pairs
06/17/2003US6579523 Transplants for myocardial scars
06/17/2003US6579522 Replication deficient adenoviral TNF vector
06/17/2003US6579521 Methods of therapy for HIV infection
06/17/2003US6579459 System and method for performing polynucleotide separations using liquid chromatography
06/17/2003CA2399408C Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
06/17/2003CA2301539C Method of making high density arrays
06/17/2003CA2222128C Surface anchoring vector and system for foreign proteins thereof
06/17/2003CA2129820C Dna sequences encoding novel growth/differentiation factors
06/17/2003CA2124928C Hbv amplifier probes for use in solution phase sandwich hybridization assays
06/17/2003CA2123315C Therapeutic agents which are antagonists or partial agonists of human interleukin 4
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/17/2003CA2071594C Methods for nucleic acid amplification
06/17/2003CA1341432C Variants of plasminogen activators and processes for their production
06/13/2003CA2410164A1 Method for determining chum salmon haplotype using mitochondrial dna
06/13/2003CA2371460A1 Cell culture system and methods of use
06/12/2003WO2003048902A2 Library screening
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003WO2003048768A2 Protein arrays for allelic variants and uses thereof
06/12/2003WO2003048395A1 Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
06/12/2003WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003WO2003048387A2 Labelled nucleotides
06/12/2003WO2003048384A2 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048377A2 Multiplex real-time quantitative pcr
06/12/2003WO2003048375A1 Hybrid glycosylated products and their production and use
06/12/2003WO2003048371A2 Dna vaccine
06/12/2003WO2003048370A1 Method for screening molecules modulating gene expression, cell lines, preparation and uses
06/12/2003WO2003048369A2 Method of transforming intact plants
06/12/2003WO2003048368A2 Plants having altered abscisic acid (aba) sensitivity
06/12/2003WO2003048367A1 Genetic strain optimization for improving the production of riboflavin
06/12/2003WO2003048366A1 Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
06/12/2003WO2003048365A1 Fungal elicitor
06/12/2003WO2003048364A2 Ovomucoid promoter and methods of use
06/12/2003WO2003048362A2 Suppression of polymeric alleles
06/12/2003WO2003048359A1 Markers for sugar/lipid metabolic disorders and utilization thereof
06/12/2003WO2003048356A1 Screening methods employing fish model assessment of vision
06/12/2003WO2003048354A1 Protein-decomposing/eliminating enzyme and utilization thereof
06/12/2003WO2003048353A1 Polypeptides having protease activity and nucleic acids encoding same
06/12/2003WO2003048352A2 Histone h3 methyltransferase polypeptide
06/12/2003WO2003048351A1 Mutated 6-phosphogluconate dehydrogenase
06/12/2003WO2003048350A1 Regulation of human lactate dehydrogenase
06/12/2003WO2003048349A2 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
06/12/2003WO2003048348A2 Production of viruses, viral isolates and vaccines
06/12/2003WO2003048346A1 Gene targeting methods and vectors
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048344A2 Differentiation of human embryonic stem cells in avian embryos
06/12/2003WO2003048339A2 Nucleic acid molecules from rice encoding rar1 disease resistance proteins and uses thereof
06/12/2003WO2003048338A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
06/12/2003WO2003048337A2 Antibody to latent membrane proteins and uses thereof
06/12/2003WO2003048331A2 Antisense modulation of phospholipid scramblase 4 expression
06/12/2003WO2003048329A2 Chromosomal saturation mutagenesis
06/12/2003WO2003048328A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003WO2003048327A2 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
06/12/2003WO2003048325A2 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
06/12/2003WO2003048324A2 Antisense modulation of phospholipid scramblase 3 expression
06/12/2003WO2003048319A2 Nucleotide sequences encoding proteins conferring abiotic stress tolerance in plants
06/12/2003WO2003048318A2 Methods for the identification of genetic features
06/12/2003WO2003048315A2 Antisense modulation of mdm2 expression
06/12/2003WO2003048314A2 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
06/12/2003WO2003048311A2 Regulated expression of recombinant dna
06/12/2003WO2003048310A2 Thermus oshimai nucleic acid polymerases
06/12/2003WO2003048309A2 Thermus thermophilus nucleic acid polymerases
06/12/2003WO2003048306A2 Polycistronic expression of antibodies
06/12/2003WO2003048303A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/12/2003WO2003048298A2 Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
06/12/2003WO2003048210A1 Fusion protein having enhanced in vivo erythropoietin activity
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048208A2 Expression control using variable intergenic sequences
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048204A1 Alzheimer’s disease-associated gene and protein and use thereof
06/12/2003WO2003048202A2 Nf-kappab activating genes
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048186A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
06/12/2003WO2003048184A2 Flavivirus ns1 subunit vaccine
06/12/2003WO2003048178A2 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003WO2003047684A2 Method for intracellular modifications within living cells using pulsed electric fields
06/12/2003WO2003047634A2 Nucleic acids and methods for treating ebv-positive cancers
1 ... 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 ... 4023